SAN ANTONIO , Sept. 29, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology ...
News
- Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership ...
- A feasibility study for a potential new ACS campus on the city's East Side just got fundedBioscience-Medicine · Border & Immigration · Economy & Labor · Criminal ... The San Antonio Inner City Tax Increment Reinvestment Zone (TIRZ) board ... 
- Kala Bio lays off 51% of workforce after eye drug fails trial - San Francisco Business TimesSan Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech company to lay off half its workforce after eye drug fails ... 
- Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership ...SAN ANTONIO, Sept. ... This recognition highlights Viva Biotech's consistent leadership in combining artificial intelligence with laboratory-driven ... 
- bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering | News | bakersfield.comSAN ANTONIO--(BUSINESS WIRE)--Sep 29, 2025--. bioAffinity Technologies, Inc.(NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for ... 
